William Coleman, MD
Procedural Dermatology · Metairie, LANPI 1104038439
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Merz North America, Inc. at 49.9% of the total. Reporting peaked in 2019 at $2,682 and has fallen 90.0% since, to $267 in 2025.
Across 73 payments — averaging $71.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$3K
- AbbVie$2K
- Sanofi$266
- E.r. Squibb & Sons, L.L.C.$178
- Endo Pharmaceuticals Inc.$68
- Amgen$60
- plus $131 from 4 others
Across 80 payments — averaging $13,259 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$673K
- Endo Pharmaceuticals Inc.$359K
- Bausch Health US, LLC$29K
What the payments were for
- Consulting fees$2,61050%
- Travel & lodging$1,16422%
- Food & beverage$1,45428%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 2 | $2,615 |
| AbbVie(2 entities) | 47 | $1,919 |
| Sanofi | 12 | $266 |
| E.r. Squibb & Sons, L.L.C. | 2 | $178 |
| Endo Pharmaceuticals Inc. | 1 | $68 |
| Amgen | 4 | $60 |
| Revance Therapeutics, Inc. | 1 | $58 |
| Galderma Laboratories, L.p. | 2 | $34 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $23 |
| Journey Medical Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few procedural dermatology providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 12 | $42,900 |
| Doxycycline Hyclate | 166 | $3,188 |
| Betamethasone Dipropionate | 60 | $2,880 |
| Finasteride | 131 | $1,302 |
| Fluocinonide | 35 | $1,284 |
| Dutasteride | 44 | $1,261 |
| Minoxidil | 80 | $1,056 |
| Ketoconazole | 80 | $954 |
| ValacyclovirValacyclovir Hcl | 36 | $941 |
| Triamcinolone Acetonide | 129 | $855 |
| Hydrocortisone | 63 | $702 |
| Clobetasol Propionate | 19 | $522 |
| Spironolactone | 34 | $518 |
| Mupirocin | 50 | $426 |
| Clotrimazole | 22 | $224 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Metairie
- Douglas KoppelMetairie$75K
- Rene KoppelMetairie$6K
- Carter PaddockMetairie$4K
- William ColemanMetairie$2K
- Mary LupoNew Orleans$91K
- Jack Murphyla Place$6K
- Maurice VickBaton Rouge$5K
- Gordon RussoGretna$3K
- Michael LindleyNew Orleans$1K
- Chad PratherBaton Rouge$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.